Abstract
Neuroinflammation is associated with the progression of multiple neurological diseases. Many studies show that SIRT2 involves in multiple inflammatory processes. While, the mechanisms remain unclear. The purpose of this study was to explore the effect of SIRT2 inhibitor AGK2 on inflammatory responses and MAPK signaling pathways in LPS activated microglia in vitro and in vivo. The effect of AGK2 on cell viability of BV2 microglial cells was detected by CCK-8 assay. The expression of inflammatory cytokine iNOS was analyzed by western blotting and immunofluorescence. The mRNA expressions of iNOS, TNF-α, and IL-1β were detected by real-time polymerase chain reaction (RT-PCR). The SIRT2, phospho-P38, P38, phospho-JNK, JNK, phospho-ERK, ERK, α-tubulin, and acetyl-α-tubulin were analyzed by western blotting respectively. The interaction between SIRT2 and MKP-1 was measured by Co-immunoprecipitation (Co-IP) assay. Double immunofluorescent staining was performed to detect the expressions of CD11b and iNOS or SIRT2 in brain tissues. We found that AGK2 could suppress LPS-induced inflammatory cytokines (iNOS, TNF-α, and IL-1β) expression levels in BV2 microglial cells. Moreover, it could effectively reduce the expression of SIRT2 and increase the acetylation of α-tubulin in LPS activated BV2 microglial cells and LPS induced mice neuroinflammation. In addition, our results showed that AGK2 could reduce the increase of phosphorylation p38, JNK, and ERK after LPS challenge. Co-IP results showed that there was no direct interaction between MKP-1 and SIRT2. However, AGK2 by inhibition of SIRT2 could increase the expression of MKP-1. Furthermore, AGK2 could inhibit the activation of BV2 microglia and expression of iNOS and SIRT2 in LPS treated mice brain tissue. Taken together, our results suggested that AGK2 might alleviate lipopolysaccharide induced neuroinflammation through regulation of mitogen-activated protein kinase phosphatase-1.
Similar content being viewed by others
References
Brown GC (2007) Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem Soc Trans 35(Pt 5):1119–1121
Cao W, Bao C, Padalko E, Lowenstein CJ (2008) Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits toll-like receptor signaling. J Exp Med 205(6):1491–1503. https://doi.org/10.1084/jem.20071728
Catorce MN, Gevorkian G (2016) LPS-induced murine Neuroinflammation model: main features and suitability for pre-clinical assessment of Nutraceuticals. Curr Neuropharmacol 14(2):155–164
Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410(6824):37–40
Chen H, Wu D, Ding X, Ying W (2015) SIRT2 is required for lipopolysaccharide-induced activation of BV2 microglia. Neuroreport 26(2):88–93. https://doi.org/10.1097/WNR.0000000000000305
Das A, Kim SH, Arifuzzaman S, Yoon T, Chai JC, Lee YS, Park KS, Jung KH, Chai YG (2016) Transcriptome sequencing reveals that LPS-triggered transcriptional responses in established microglia BV2 cell lines are poorly representative of primary microglia. J Neuroinflammation 13(1):182. https://doi.org/10.1186/s12974-016-0644-1
Dong C, Davis RJ, Flavell RA (2002) MAP kinases in the immune response. Annu Rev Immunol 20:55–72
Gomes P, Fleming Outeiro T, Cavadas C (2015) Emerging role of Sirtuin 2 in the regulation of mammalian metabolism. Trends Pharmacol Sci 36(11):756–768. https://doi.org/10.1016/j.tips.2015.08.001
Hammer M, Mages J, Dietrich H, Servatius A, Howells N, Cato AC, Lang R (2006) Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J Exp Med 203(1):15–20
Harrison IF, Smith AD, Dexter DT (2018) Pathological histone acetylation in Parkinson’s disease: neuroprotection and inhibition of microglial activation through SIRT 2 inhibition. Neurosci Lett 666:48–57. https://doi.org/10.1016/j.neulet.2017.12.037
Henn A, Lund S, Hedtjärn M, Schrattenholz A, Pörzgen P, Leist M (2009) The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX 26(2):83–94
Hickman S, Izzy S, Sen P, Morsett L, El Khoury J (2018) Microglia in neurodegeneration. Nat Neurosci 21(10):1359–1369. https://doi.org/10.1038/s41593-018-0242-x
Hoogland IC, Houbolt C, van Westerloo DJ, van Gool WA, van de Beek D (2015) Systemic inflammation and microglial activation: systematic review of animal experiments. J Neuroinflammation 12:114. https://doi.org/10.1186/s12974-015-0332-6
Jung YJ, Lee AS, Nguyen-Thanh T, Kim D, Kang KP, Lee S, Park SK, Kim W (2015) SIRT2 regulates LPS-induced renal tubular CXCL2 and CCL2 expression. J Am Soc Nephrol 26(7):1549–1560. https://doi.org/10.1681/ASN.2014030226
Kim HS, Vassilopoulos A, Wang RH, Lahusen T, Xiao Z, Xu X, Li C, Veenstra TD, Li B, Yu H, Ji J, Wang XW, Park SH, Cha YI, Gius D, Deng CX (2011) SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity. Cancer Cell 20(4):487–499. https://doi.org/10.1016/j.ccr.2011.09.004
Korhonen R, Moilanen E (2014) Mitogen-activated protein kinase phosphatase 1 as an inflammatory factor and drug target. Basic Clin Pharmacol Toxicol 114(1):24–36. https://doi.org/10.1111/bcpt.12141
Lawan A, Shi H, Gatzke F, Bennett AM (2013) Diversity and specificity of the mitogen-activated protein kinase phosphatase-1 functions. Cell Mol Life Sci 70(2):223–237. https://doi.org/10.1007/s00018-012-1041-2
Lee AS, Jung YJ, Kim D, Nguyen-Thanh T, Kang KP, Lee S, Park SK, Kim W (2014) SIRT2 ameliorates lipopolysaccharide-induced inflammation in macrophages. Biochem Biophys Res Commun 450(4):1363–1369. https://doi.org/10.1016/j.bbrc.2014.06.135
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25(4):402–408
Mendes KL, Lelis DF, Santos SHS (2017) Nuclear sirtuins and inflammatory signaling pathways. Cytokine Growth Factor Rev 38:98–105. https://doi.org/10.1016/j.cytogfr.2017.11.001
North BJ, Marshall BL, Borra MT, Denu JM, Verdin E (2003) The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 11(2):437–444
Ory D, Celen S, Verbruggen A, Bormans G (2014) PET radioligands for in vivo visualization of neuroinflammation. Curr Pharm Des 20(37):5897–5913
Pais TF, Szegő ÉM, Marques O, Miller-Fleming L, Antas P, Guerreiro P, de Oliveira RM, Kasapoglu B, Outeiro TF (2013) The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation. EMBO J 32(19):2603–2616. https://doi.org/10.1038/emboj.2013.200
Rahimifard M, Maqbool F, Moeini-Nodeh S, Niaz K, Abdollahi M, Braidy N, Nabavi SM, Nabavi SF (2017) Targeting the TLR4 signaling pathway by polyphenols: a novel therapeutic strategy for neuroinflammation. Ageing Res Rev 36:11–19. https://doi.org/10.1016/j.arr.2017.02.004
Schwartz M, Deczkowska A (2016 Oct) Neurological disease as a failure of brain-immune crosstalk: the multiple faces of Neuroinflammation. Trends Immunol 37(10):668–679. https://doi.org/10.1016/j.it.2016.08.001
Serrano L, Martínez-Redondo P, Marazuela-Duque A, Vazquez BN, Dooley SJ, Voigt P, Beck DB, Kane-Goldsmith N, Tong Q, Rabanal RM, Fondevila D, Muñoz P, Krüger M, Tischfield JA, Vaquero A (2013) The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation. Genes Dev 27(6):639–653. https://doi.org/10.1101/gad.211342.112
Song GJ, Suk K (2017) Pharmacological modulation of functional phenotypes of microglia in neurodegenerative diseases. Front Aging Neurosci 9:139. https://doi.org/10.3389/fnagi.2017.00139
Suzuki T, Khan MN, Sawada H, Imai E, Itoh Y, Yamatsuta K, Tokuda N, Takeuchi J, Seko T, Nakagawa H, Miyata N (2012) Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors. J Med Chem 55(12):5760–5773. https://doi.org/10.1021/jm3002108
Wang B, Zhang Y, Cao W, Wei X, Chen J, Ying W (2016) SIRT2 plays significant roles in lipopolysaccharides-induced Neuroinflammation and brain injury in mice. Neurochem Res 41(9):2490–2500. https://doi.org/10.1007/s11064-016-1981-2
Wang J, Koh HW, Zhou L, Bae UJ, Lee HS, Bang IH, Ka SO, Oh SH, Bae EJ, Park BH (2017) Sirtuin 2 aggravates postischemic liver injury by deacetylating mitogen-activated protein kinase phosphatase-1. Hepatology 65(1):225–236. https://doi.org/10.1002/hep.28777
Xanthos DN, Sandkühler J (2014) Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity. Nat Rev Neurosci 15(1):43–53. https://doi.org/10.1038/nrn3617
Xie XQ, Zhang P, Tian B, Chen XQ (2017) Downregulation of NAD-dependent Deacetylase SIRT2 protects mouse brain against ischemic stroke. Mol Neurobiol 54(9):7251–7261. https://doi.org/10.1007/s12035-016-0173-z
Zhao Q, Wang X, Nelin LD, Yao Y, Matta R, Manson ME, Baliga RS, Meng X, Smith CV, Bauer JA, Chang CH, Liu Y (2006) MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med 203(1):131–140
Zhao T, Alam HB, Liu B, Bronson RT, Nikolian VC, Wu E, Chong W, Li Y (2015) Selective inhibition of SIRT2 improves outcomes in a lethal septic model. Curr Mol Med 15(7):634–641
Acknowledgments
This study was supported by a grant from the National Natural Science Foundation of China (No. 81870413).
Author information
Authors and Affiliations
Contributions
Fangzhou Jiao and Zuojiong Gong designed research; Fangzhou Jiao performed research; Yao Wang, Wenbin Zhang, Haiyue Zhang, Qian Chen and Luwen Wang analyzed and interpreted the data. Chunxia Shi performed supplementary experiment and corrected English errors in paper. Fangzhou Jiao and Zuojiong Gong wrote the paper.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jiao, F., Wang, Y., Zhang, W. et al. AGK2 Alleviates Lipopolysaccharide Induced Neuroinflammation through Regulation of Mitogen-Activated Protein Kinase Phosphatase-1. J Neuroimmune Pharmacol 15, 196–208 (2020). https://doi.org/10.1007/s11481-019-09890-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-019-09890-x